
|Articles|March 10, 2008
Clinical twisters: Addressing CVA prophylaxis
This case study assesses the need for anticoagulation and the drugs of choice for prophylaxis against cerebrovascular accidents (strokes) in patients with previous CVAs of different origins.
Advertisement
Nancy L. Shapiro, Pharm.D., BCPSAimee Chevalier, Pharm.D.
Clinical Pharmacists, Antithrombosis Clinic
Clinical Assistant Professor, Dept. of Pharmacy Practice
University of Illinois at Chicago College of Pharmacy
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Variation in Insulin Pump Options Creates Opportunity for Pharmacist Counseling | ASHP Midyear 2025
2
Q&A: How Complex US Drug Market Impedes MFN Pricing Policy
3
Expert Addresses Pharmacy’s Uncertainty Amid MFN Drug Pricing Policy
4
OTC Products: Cold and Flu
5























































































































